Pseudolycorine chloride ameliorates Th17 cell-mediated central nervous system autoimmunity by restraining myeloid-derived suppressor cell expansion

Context The alkaloids of Narcissus tazetta L. var. Chinensis Roem (Amaryllidaceae) have antitumor and antiviral activities. However, the immunopharmacological effects of one of its constituents, pseudolycorine chloride (PLY), have not been reported yet. Objective We evaluated the effect of PLY on myeloid-derived suppressor cells (MDSCs) expansion and differentiation into monocyte-like MDSCs (M-MDSCs) and examined whether PLY alleviates Th17 cell-mediated experimental autoimmune encephalomyelitis (EAE), a murine model of multiple sclerosis (MS). Materials and methods In vitro, MDSCs were treated with PLY (0.67, 2 and 6 mu M) or solcitinib (10 mu M, positive control) for 48 or 96 h, and their proliferation, expansion, and differentiation into M-MDSCs were examined by flow cytometry. Myelin oligodendrocyte glycoprotein (MOG(35-55)) was used to induce EAE in female C57BL/6 mice, and the mice were treated with 40 mg/kg/d PLY or 1 mg/kg/d FK-506 (tacrolimus, positive control) for 21 days. Inflammatory infiltration, spinal cord demyelination, and MDSCs and Th17 cells infiltration into the spinal cord were examined using haematoxylin and eosin staining, Luxol fast blue staining, and immunofluorescence, respectively. Results In vitro, PLY (IC50/24 h = 6.18 mu M) significantly inhibited IL-6 and GM-CSF-induced MDSCs proliferation, expansion and differentiation into M-MDSCs at all concentrations used. However, these concentrations did not show cytotoxicity. In mice, PLY (40 mg/kg) treatment alleviated EAE and inhibited inflammatory infiltration, demyelination, and MDSCs and Th17 cells infiltration into the spinal cord. Discussion and conclusions PLY may be an excellent candidate for the treatment of MS and other autoimmune diseases.

Automated summary

This study evaluated the effects of pseudolycorine chloride (PLY), a constituent of Narcissus tazetta L. var. Chinensis Roem, on myeloid-derived suppressor cells (MDSCs) expansion and differentiation, and examined its therapeutic potential in experimental autoimmune encephalomyelitis (EAE), a murine model of multiple sclerosis (MS). In vitro and in vivo experiments showed that PLY inhibited MDSCs proliferation, expansion, and differentiation, and alleviated EAE symptoms by reducing inflammatory infiltration and demyelination.